Error: Could not add to watchlist. X

Bradmer Pharmaceuticals Inc

+ Watchlist
BMR/H:CN
Venture
CAD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
0.00
Market Cap (CAD)
-
Shares Outstanding (m)
19.660
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma
There are currently no news stories for this ticker. Please check back later.
Profile
Bradmer Pharmaceuticals Inc. is a biotechnology company focused on development and commercialization of cancer therapies. The lead product candidate, Neuradiab, is a therapy against certain brain cancers.
ADDRESS
Wildeboer Dellelce Place
365 Bay Street Suite 800
Toronto, ON M5H 2V1
Canada
PHONE
1-416-361-6058
  • Alan Mark Ezrin
    Chairman/President/CEO
  • Paul J Van Damme
    Managing Director
Show More